Mechanisms of Weight Loss After Obesity Surgery
Open accessThe DOI matches its Crossref record; 154 of the 155 references it cites were found in a registry or an index.
Abstract
Obesity surgery remains the most effective treatment for obesity and its complications. Weight loss was initially attributed to decreased energy absorption from the gut but has since been linked to reduced appetitive behavior and potentially increased energy expenditure. Implicated mechanisms associating rearrangement of the gastrointestinal tract with these metabolic outcomes include central appetite control, release of gut peptides, change in microbiota, and bile acids. However, the exact combination and timing of signals remain largely unknown. In this review, we survey recent research investigating these mechanisms, and seek to provide insights on unanswered questions over how weight loss is achieved following bariatric surgery which may eventually lead to safer, nonsurgical weight-loss interventions or combinations of medications with surgery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Looking for the next step in obesity pharmacotherapies, the concept of combining entero-pancreatic hormones for obesity treatment was supported by the marked WL, sustained weight maintenance, and metabolic benefits observed with BS, which increase multiple gut hormone levels [9–14].”
From Triple Agonism Based Therapies for Obesity (2025) · cites this paper as [9]
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 3×
“Chronic infusion of the selective GLP-1 receptor antagonist exendin-(9-30) into the lateral cerebral ventricle significantly increased energy intake and body weight in both RYGB and sham-operated rats, while chronic infusion of a selective Y2receptor antagonist had no effect in either group (90).”
BackgroundMethodA human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Bariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451 · cited 3×
“Chronic infusion of the selective GLP-1 receptor antagonist exendin-(9-30) into the lateral cerebral ventricle significantly increased energy intake and body weight in both RYGB and sham-operated rats, while chronic infusion of a selective Y2receptor antagonist had no effect in either group (90).”
BackgroundMethodEffects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Identification and Importance of Brown Adipose Tissue in Adult Humans
Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A. B., Kuo, F. C., Palmer, E. L., Tseng, Y.-H., Doria, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810780 · Cited by 4,399
Introduction to the human gut microbiota
Thursby, E., & Juge, N. (2017) · Biochemical Journal · doi:10.1042/bcj20160510 · Cited by 3,600
Role of the normal gut microbiota
Jandhyala, S. M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i29.8787 · Cited by 3,001
Research works printed but not linked: 1
- Goldstone, 2016, Link between increased satiety gut hormones and reduced food reward after gastric bypass surgery for obesity, J Clin Endocrinol Metab., 101, 599, 10.1210/jc.2015-2665 · DOI · Paper page
Cited by
Lingvay, I., Cohen, R. V., Roux, C. W. L., & Sumithran, P. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01210-8 · Cited by 433
Molecular basis of bile acid-FXR-FGF15/19 signaling axis
Katafuchi, T., & Makishima, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116046 · Cited by 193
“FGF19 levels can increase following bariatric surgery and this increase is involved in postoperative body weight loss [168].”
BackgroundSarma, S., & Palcu, P. (2022) · Obesity · doi:10.1002/oby.23563 · Cited by 133
“Humoural and neural gut signaling may lower the established body weight setpoint, resulting in reduced weight regain [49].”
BackgroundGut hormone co-agonists for the treatment of obesity: from bench to bedside
Nogueiras, R., Nauck, M. A., & Tschöp, M. H. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00812-z · Cited by 102
Nutritional Management in Bariatric Surgery Patients
Deledda, A., Pintus, S., Loviselli, A., Fosci, M., Fantola, G., & Velluzzi, F. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182212049 · Cited by 54
“On the other hand, in the case of reduced microbiota diversity subsequent to weight loss, the risk of weight-regain increases [63].”
BackgroundCampos, A., Cifuentes, L., Hashem, A. M., Busebee, B. T., Andrade, M. D. H., Ricardo-Silgado, M. L., MCRAE, A. N., la Rosa, A. D., Feris, F., Bublitz, J. T., et al. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06122-9 · Cited by 47
“However, in the mid- and long-term, the impaired ligands and receptors in the pathway may cease to respond to the post-RYGB hormonal adaptations, leading to a progressive and substantial weight regain [44, 45].”
BackgroundCOHEN, R. V., Park, J. Y., Prager, G., Bueter, M., le Roux, C. W., Parmar, C. D., Kermansaravi, M., Salminen, P. T. P., & Miras, A. D. (2024) · British journal of surgery · doi:10.1093/bjs/znae284 · Cited by 50
Self-citationFood Intake Following Gastric Bypass Surgery: Patients Eat Less but Do Not Eat Differently
Livingstone, M. B. E., Redpath, T., Naseer, F., Boyd, A., Martin, M., Finlayson, G., Miras, A. D., Bodnár, Z., Kerrigan, D. D., Pournaras, D. J., et al. (2022) · Journal of Nutrition · doi:10.1093/jn/nxac164 · Cited by 48
“(B) Eating occasion amount (g), group: F(1, 54) = 2.”
InfluentialSelf-citationJakubowska, A., Roux, C. W. L., & Viljoen, A. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.1942 · Cited by 45
Development and complications of nutritional deficiencies after bariatric surgery
Steenackers, N., der Schueren, B. V., Augustijns, P., Vanuytsel, T., & Matthys, C. (2022) · Nutrition Research Reviews · doi:10.1017/s0954422422000221 · Cited by 52
New insights in the mechanisms of weight‐loss maintenance: Summary from a Pennington symposium
Flanagan, E. W., Spann, R., Berry, S. E., Berthoud, H., Broyles, S., Foster, G. D., Krakoff, J., Loos, R. J. F., Lowe, M. R., Ostendorf, D. M., et al. (2023) · Obesity · doi:10.1002/oby.23905 · Cited by 40
“Additionally, patients of both vertical sleeve gastrectomy and Roux-en-Y gastric bypass report a decrease in hunger and hedonic appeal of food [57], supported by functional magnetic resonance imaging studies [58, 59].”
BackgroundLiu, H., Lefere, S., Guillot, A., Zheng, M., & Tacke, F. (2025) · Hepatology · doi:10.1097/hep.0000000000001417 · Cited by 44
Laparoscopy-assisted versus balloon enteroscopy-assisted ERCP after Roux-en-Y gastric bypass
Tønnesen, C. J., Young, J., Glomsaker, T. B., Mala, T., Løberg, M., Bretthauer, M., Refsum, E., & Aabakken, L. (2020) · Endoscopy · doi:10.1055/a-1139-9313 · Cited by 37
Tan, M. M. C., Jin, X., Taylor, C., Low, A. K., Page, P. L., Martin, D., Li, A., Joseph, D., & Kormas, N. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154466 · Cited by 36
Liu, J., Jing, C., Guo, Y., Shang, Z., Zhang, B., Zhou, X., Zhang, J., Lian, G., Tian, F., Li, L., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06656-3 · Cited by 29
“For example, certain gut microbiota produce short-chain fatty acids, which stimulate the secretion of GLP-1 via free fatty acid receptor-2 [61, 107].”
Sabatella, L., Ortega, P., Valentí, V., Rotellar, F., Pagola, A. U., Ahmed, A., Purkayastha, S., Tuero, C., Blanco, N., & Landecho, M. F. (2025) · Obesity · doi:10.1002/oby.70100 · Cited by 32
“MBS induces persistent anatomical and neurohormonal changes that yield durable weight reduction and metabolic improvement, with weight regain typically limited and occurring gradually over time [43–45].”
A review on the potential use of natural products in overweight and obesity
Li, X., Zhang, Y., Wang, S., Shi, C., Wang, S., Wang, X., & Lü, X. (2022) · Phytotherapy Research · doi:10.1002/ptr.7426 · Cited by 29
Koschker, A., Warrings, B., Morbach, C., Seyfried, F., Jung, P., Dischinger, U., Edelmann, F., Herrmann, M. J., Stier, C. K., Frantz, S., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155655 · Cited by 29
Obesity wars: hypothalamic sEVs a new hope
Mukherjee, S., Diéguez, C., Fernø, J., & López, M. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.04.006 · Cited by 26
Zhao, S., Lin, H., Li, W., Xu, X., Wu, Q., Wang, Z., Shi, J., Chen, Y., Ye, L., Xi, L., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2462261 · Cited by 26
Mahabamunuge, J., Sekula, N. M., Lepore, C., Kudrimoti, M., Upadhyay, A., Alshowaikh, K., Li, H. J., Seifer, D. B., & AlAshqar, A. (2025) · Biomedicines · doi:10.3390/biomedicines13030709 · Cited by 30
“…an energy replete state at the level of the hypothalamus, and increased bile acid production, which leads to increased fatty acid oxidation and stimulation of GLP-1 and peptide YY in the small intestine, both promote anorexigenic gut hormone production in patients after bariatric surgery [202,203].”
Bariatric Surgery in Women with Polycystic Ovary Syndrome
Samarasinghe, S., Woods, C., & Miras, A. D. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155745 · Cited by 27
Self-citationTriple Agonism Based Therapies for Obesity
Goldney, J., Hamza, M., Surti, F., Davies, M. J., & Papamargaritis, D. (2025) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-025-00770-z · Cited by 22
“Looking for the next step in obesity pharmacotherapies, the concept of combining entero-pancreatic hormones for obesity treatment was supported by the marked WL, sustained weight maintenance, and metabolic benefits observed with BS, which increase multiple gut hormone levels [9– 14 ].”
Dischinger, U., Kötzner, L., Kovatcheva‐Datchary, P., Kleinschmidt, H., Haas, C., Perez, J., Presek, C., Koschker, A., Miras, A. D., Hankir, M. K., et al. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155341 · Cited by 22
“These changes in eating behavior are mediated by changes in gut-derived signals, such as altered postprandial levels of anorexic gut hormones [15 – 17], bile acid signaling [18], changes in gut microbiota and associated neuro-modulatory metabolites [19 – 23] and other not yet identified factors.”
Self-citationThe Black Box Orchestra of Gut Bacteria and Bile Acids: Who Is the Conductor?
Majait, S., Nieuwdorp, M., Kemper, E. M., & Soeters, M. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031816 · Cited by 23
“Nevertheless, with the exception of the RYGB it can be concluded that a higher gut microbiome diversity is associated with lower, and in particular secondary, bile acids.”
BackgroundInfluentialThe circulating and central endocannabinoid system in obesity and weight loss
Mattelaer, N., der Schueren, B. V., Oudenhove, L. V., Weltens, N., & Vangoitsenhoven, R. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01553-z · Cited by 24
Gallstones after bariatric surgery: mechanisms and prophylaxis
Chen, S., Zheng, Y., Cai, J., Wu, Y., & Chen, X. (2025) · Frontiers in Surgery · doi:10.3389/fsurg.2025.1506780 · Cited by 25
“Evidence suggests that levels of both GLP-1 and GLP-2 increase after bariatric surgery (36).”
InfluentialObesity and its management in primary care setting
Ibrahim, M. A., Ba-Essa, E. M., Alvarez, J. A., Baker, J. C., Bruni, V., Cahn, A., Ceriello, A., Cosentino, F., Davies, M. J., Domenico, F. D., et al. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109045 · Cited by 21
Dietary patterns interfere with gut microbiota to combat obesity
Lou, X., Li, P., Luo, X., Lei, Z., Liu, X., Liu, Y., Gao, L., Xu, W., & Liu, X. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1387394 · Cited by 21
“After transferring fecal material from mice that have undergone Roux-en-Y gastric bypass into the gut of non-operated GF mice (23), the GF mice develop a weight loss and fat loss phenotype (24).”
BackgroundA review on the beneficial effects of bariatric surgery in the management of obesity
Wahab, R. A., & le Roux, C. W. (2022) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2110865 · Cited by 22
“isms of weight loss following surgery have been linked to alterations in the central appetite control, gut microbiota, gut peptides, and bile acids [9].”
BackgroundGut microbiota changes associated with low-carbohydrate diet intervention for obesity
Li, L., Zhao, X., Abdugheni, R., Yu, F., Zhao, Y., Ma, B.-F., Zhifang, Y., Li, R., Li, Y., Maimaitiyiming, Y., et al. (2024) · Open Life Sciences · doi:10.1515/biol-2022-0803 · Cited by 21
“These include pharma-cotherapy [12], surgical treatment [13], exercise therapy [9], and dietary interventions among others [14], all of which have pros and cons, respectively.”
Penney, N. C., Yeung, K. T. D., García‐Pérez, I., Posma, J. M., Kopytek, A., Garratt, B., Ashrafian, H., Frost, G. S., Marchesi, J. R., Purkayastha, S., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00185-6 · Cited by 16
Delayed Gastric Emptying After Sleeve Gastrectomy Is Associated with Poor Weight Loss
Wickremasinghe, A., Johari, Y., Laurie, C., Shaw, K., Playfair, J., Beech, P., Yue, H., Becroft, L., Hebbard, G., Yap, K. S. K., et al. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06323-2 · Cited by 17
“Complex mechanisms such as alterations in entero-hepatic bile circulation, changes in the microbiome, or alterations in GI hormones are suggested as the direct mechanism of weight loss following SG [20, 21].”
BackgroundNavarro-Marroco, J., Hernández-Sánchez, P., Victoria‐Montesinos, D., Barcina-Pérez, P., Lucas-Abellán, C., & García‐Muñoz, A. M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13226784 · Cited by 16
Fiorenza, M., Checa, A., Sandsdal, R. M., Jensen, S. B. K., Juhl, C. R., Noer, M. H., Bogh, N. P., Lundgren, J. R., Janus, C., Stallknecht, B. M., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101629 · Cited by 14
“85 Thus, while surgery-induced weight loss is mediated by neural pathways beyond those targeted by GLP-1RA therapy or exercise, 86 data from obesity surgery studies suggest a decrease in FGF21 following long-term weight-loss maintenance.”
Weight Recidivism After Bariatric Surgery: A Narrative Review
Cao, Q., Kazi, H., Merchant, A. M., & Jawed, A. E. (2025) · The American Surgeon · doi:10.1177/00031348251337161 · Cited by 14
“19 Further studies to elucidate the biochemical role of ghrelin in weight loss and weight regain in the setting of RYGBP are clearly required.”
Sarcopenic Obesity in Metabolic and Bariatric Surgery: A Scoping Review
Vieira, F. T., Prado, C. M. M., Thorlakson, J. J. D., Stoklossa, C. J., Jin, J., Donini, L. M., Gramlich, L. M., & Bielawska, B. (2025) · Obesity Reviews · doi:10.1111/obr.13973 · Cited by 18
Torres, S. Y. L., Aukan, M. I., Gower, B. A., & Martins, C. (2024) · Obesity · doi:10.1002/oby.24031 · Cited by 16
“Both RYGB and SG have been shown to increase the postprandial secretion of satiety peptides GLP-1 and PYY [32] but have also been shown to have different effects on ghrelin [32, 33].”
BackgroundGala, K. S., Ghusn, W., Fansa, S., Dayyeh, B. K. A., Ghanem, O. M., Kellogg, T. A., & Acosta, A. J. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06462-0 · Cited by 13
Picoli, C. C., Tsibulnikov, S., Ho, M., DeMambro, V., Feng, T., Eltahir, M., Le, P. T., Chlebek, C., Rosen, C. J., Ryzhov, S. V., et al. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00521.2024 · Cited by 13
“Additional mechanisms such as shifts in food preference and changes in energy expenditure also contribute to weight reduction but in a more complex manner (50).”
Host–Microbiome Interaction in the Intensive Care Unit
Neag, M. A., Mitre, A. O., Pomana, I. G., Velescu, M. A., Militaru, C. F., Nagy, G. A., & Melincovici, C. S. (2025) · Diseases · doi:10.3390/diseases13080250 · Cited by 14
“FGF15/19 is involved in hepatic fatty acid synthesis and lipid metabolism, reducing lipid levels and accumulation [40,41].”
Obesity and climate change: co-crises with common solutions
Behrens, P., Champagne, C. M., Halford, J. C. G., Moodie, M., Proietto, J., Rutter, G. A., Samaras, K., & Holly, J. M. P. (2025) · Frontiers in Science · doi:10.3389/fsci.2025.1613595 · Cited by 14
“However, the actual mechanisms of weight loss are more complex and may also involve changes in neural signals affecting central appetite control, the release of gut hormones, changes in gut microbiota, and bile acids (293).”
Self-citationCardioprotective benefits of metabolic surgery and GLP-1 receptor agonist–based therapies
Morissette, A., & Mulvihill, E. E. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.07.012 · Cited by 13
Alabdulkader, S., Al‐Alsheikh, A. S., Miras, A. D., & Goldstone, A. P. (2024) · NeuroImage Clinical · doi:10.1016/j.nicl.2024.103563 · Cited by 12
“…after RYGB surgery, but fasting hormone concentrations may be unchanged or only slightly increased (Scholtz et al., 2014; Yousseif et al., 2014; Zakeri & Batterham, 2018; Akalestou et al., 2022), food cue reactivity changes would be expected to be more marked in the fed than fasted state.”
BackgroundSelf-citationStefanidis, A., Lee, C. M. C., Greaves, E., Montgomery, M. K., Arnold, M., Newn, S., Budin, A. J., Lemus, M. B., Foldi, C. J., Burton, P. R., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101739 · Cited by 12
“While the present study has focussed on VSG, the question arises as to whether there is a common mechanistic basis for the efficacy of related resectional procedures such as RYGB where metabolic outcomes including weight loss and glycemic control are similar [30].”
BackgroundLau, T., Cook, J., Archid, R., Stengel, A., Zipfel, S., & Mack, I. (2022) · Obesity Facts · doi:10.1159/000526945 · Cited by 12
Common, Less Common, and Unexpected Complications after Bariatric Surgery: A Pictorial Essay
Iacobellis, F., Orabona, G. D., Brillantino, A., Serafino, M. D., Rengo, A., Crivelli, P., Romano, L., & Scaglione, M. (2022) · Diagnostics · doi:10.3390/diagnostics12112637 · Cited by 11
Steffen, K. J., Sorgen, A. A., Fodor, A. A., Carroll, I. M., Crosby, R. D., Mitchell, J. E., Bond, D. S., & Heinberg, L. J. (2024) · Obesity · doi:10.1002/oby.24168 · Cited by 9
“Importantly, there is limited information concerning the mechanisms that relate to weight trajectory and those that can discriminate between patients who will experience optimal versus those who will experience suboptimal outcomes [6 – 8].”
Emini, M., Bhargava, R., Aldhwayan, M., Chhina, N., Rodríguez-Flores, M., Aldubaikhi, G., Lababidi, M. A., Al‐Najim, W., Miras, A. D., Ruban, A., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae214 · Cited by 9
Self-citationOld and new anti-obesity drugs
Dodangeh, S., & Hasani‐Ranjbar, S. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01512-5 · Cited by 8
“During the weight loss phase changes in diet selection, decreased appetite, and changes in gut hormone levels are known to play a significant role [62].”
May, W., Goedecke, J. H., & Conradie-Smit, M. (2025) · South African Medical Journal · doi:10.7196/samj.2025.v115i9b.3600 · Cited by 8
“[90-93] It is important to recognise that while increased appetite is the primary final common pathway (cause) in primary obesity, genetic and secondary obesity have distinct underlying causes that can be directly targeted, such as leptin replacement therapy in leptin deficiency or treatment for…”
Weight loss to disrupt type 2 diabetes
Alsaqaaby, M. S., & le Roux, C. W. (2023) · Diabetology International · doi:10.1007/s13340-023-00626-0 · Cited by 8
“The primary benefit of these mechanisms is substantial weight loss which seems associated with a reduction in body fat mass set point, making weight loss straightforward and sustainable [41, 42].”
BackgroundNedelcut, S., Axer, S. S., & Olbers, T. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155799 · Cited by 9
Essop, T., Tran, K., Purdy, A. C., & Daly, S. C. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01554-2 · Cited by 7
“These improvements may occur through various mechanisms, such as short-chain fatty acid production, bile acid metabolism, and modulation of gut barrier function [4].”
Lammert, M., Medawar, E., Hartmann, H., Grasser, L., Dietrich, A., Fenske, W. K., & Horstmann, A. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114279 · Cited by 8
Chen, H., Guo, X., Long, T., & Li, M. (2026) · Obesity Surgery · doi:10.1007/s11695-025-08415-1 · Cited by 7
Intestinal Energy Harvest Mediates Gut Microbiota-Associated Weight Loss Following Bariatric Surgery
Qian, Y., Sorgen, A. A., Steffen, K. J., Heinberg, L. J., Reed, K., & Carroll, I. M. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07467-z · Cited by 6
“Prior research has demonstrated that MBS leads to substantial changes in the composition of the gut microbiota [2, 4, 6, 7]—the complex microbial community residing in the human gut.”
Blasi, C. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01853-y · Cited by 7
“Changes in eating behavior after obesity surgery include decreased hunger; increased satiety and fullness; decreased food hedonism, reward, and motivation; modi fi ed taste and food preferences; and potential food aversion or avoidance resulting from adverse post-ingressive symptoms [26, 51].”
Amylin, bariatric surgery, and type 2 diabetes mellitus
Lee, W.-L., Lee, F., & Wang, P. (2021) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000618 · Cited by 6
“11 Therefore, we are happy to learn the article published in the current issue of the Journal of the Chinese Medical Association with a focus on bariatric surgery-related remission of T2DM.”
Incretins and Development of Incretin‐based Therapeutics
Zheng, N., Su, X., Zhang, S., & Shen, W. (2025) · Wiley eBooks · doi:10.1002/9781119824701.ch09 · Cited by 6
The role of child development and socioeconomic factors in child obesity in Pakistan
Wang, T., Akram, S., Hassan, M. U., Khurram, F., & Shahzad, M. F. (2025) · Acta Psychologica · doi:10.1016/j.actpsy.2025.104966 · Cited by 6
Al-Fagih, O. S., Zuberi, S. J., Niaz, O., Jambulingam, P. S., Whitelaw, D., Rashid, F., Adil, M. T., Jain, V., Al‐Taan, O., Munasinghe, A., et al. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07237-x · Cited by 4
“Moreover, the contributions of fatty acid oxidation and bile acids to the overall mechanism of weight loss indicate that a comprehensive understanding of these processes is still evolving [30].”
Yang, Y., Cheng, X., Chen, S., Xie, J.-Z., Chen, G., Li, L., Feng, Y., Chen, Y., Liu, G., Yin, Y., et al. (2026) · International Journal of Surgery · doi:10.1097/js9.0000000000004566 · Cited by 5
“Bariatric metabolic surgery, including procedures like gastric bypass and sleeve gastrectomy, provides substantial and sustained weight loss by altering the anatomy and physiology of the gastrointestinal tract [ 14 ] .”
Huang, Y. S., Wen, J., wang, S., Song, Y., Zhou, B., Zhang, N., & Meng, H. (2026) · Obesity Surgery · doi:10.1007/s11695-026-08748-5 · Cited by 4
“This pattern may be related to semaglutide-facilitated gastrointestinal hormonal and metabolic remodeling [ 47], the establishment of healthier behavioral patterns [ 48], and the early formation of a more favorable long-term weight-loss trajectory.”
Zhan, D., Long, Z., Yang, H., Wang, H., He, C., Yin, J., Yu, J., Luo, F., & Liu, Y. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07157-w · Cited by 4
Neural processing of sweet taste in reward regions is reduced following bariatric surgery
Alessi, J., Džemidžić, M., Harezlak, J., Kareken, D. A., & Considine, R. V. (2024) · Obesity · doi:10.1002/oby.24103 · Cited by 5
“RYGB and SG alter serum levels of gut hormones resulting in greater satiety signaling and less hunger signaling [29], albeit with differences between the surgeries.”
Treating obesity to optimize women’s health outcomes
Rubino, D., & Schon, S. B. (2025) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002595 · Cited by 4
Body Fat Depletion: the Yin Paradigm for Treating Type 2 Diabetes
Zhu, J., & Wilding, J. P. H. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01181-4 · Cited by 4
“Metabolic surgery might remodel neural signaling in the gut-brain axis to exaggerate postprandial insulin secretion (under a relatively inadequate food/glucose stimulation) [46, 47].”
Alcohol Use After Bariatric Surgery: A Comprehensive Review of Current Knowledge and Research Gaps
Er, E., Flahault, C., & Etienne, A. (2025) · Clinical Obesity · doi:10.1111/cob.70048 · Cited by 3
Can obesity medications replace metabolic and bariatric surgery? A comprehensive review
Ko, T. Y. L., COHEN, R. V., & le Roux, C. W. (2026) · Proceedings of The Nutrition Society · doi:10.1017/s0029665126102973 · Cited by 3
Richter, L. R., Albert, B. I., Zhang, L., Ostropolets, A., Zitsman, J. L., Fennoy, I., Albers, D. J., & Hripcsak, G. M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.923704 · Cited by 4
“, glucagon-like peptide-1 (GLP-1) and ghrelin, and change bile acid composition through the change in macronutrients present in areas of the small intestine (Seeley et al., 2015; Mulla et al., 2018; Akalestou et al., 2022).”
BackgroundSingle anastomosis gastric bypass for morbid obesity
Richardsen, A. J., Chahal-Kummen, M., Kristinsson, J. A., Søvik, T. T., Eribe, I., & Mala, T. (2023) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.23.0070 · Cited by 3
Saad, B., Rahima, K., Mourad, M. M., Vankayalapati, D. K., Segun-Omosehin, O., Sulaiman, H. O., Burns, J. W. F., Nakanishi, H., Than, C. A., Syed, A. A., et al. (2025) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2025.09.003 · Cited by 3
Effect of Bariatric Surgery on Gut Microbiota: A Scientometric Analysis
Cabanillas‐Lazo, M., Quispe‐Vicuña, C., Pascual-Guevara, M., Guerrero, M. E., Barja–Ore, J., Espinoza‐Carhuancho, F., & Mayta‐Tovalino, F. (2024) · Saudi Journal of Medicine and Medical Sciences · doi:10.4103/sjmms.sjmms_146_23 · Cited by 3
“[14] Furthermore, in a bibliometric analysis, this author was the most productive in the field of gastric bypass.”
BackgroundMaghsoodlo, M., Shakibazadeh, E., Yaseri, M., Mokhtari, Z., Barzin, M., & Salimi, Y. (2025) · PLoS ONE · doi:10.1371/journal.pone.0314316 · Cited by 4
“Individuals who have undergone bariatric surgery often experience weight regain and demonstrate a lack of engagement in self-care and self-management activities following the procedure [19,45–47].”
Generation and characterization of a mouse model for one anastomosis gastric bypass surgery
Abu‐Gazala, S., Bergel, M., Arad, Y., Hefetz, L., Azulai, S., Baker, A., Haran, A., Israeli, H., Kleiman, D., Samuel, I., et al. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00416.2021 · Cited by 3
СУЧАСНІ АСПЕКТИ ПРОФІЛАКТИКИ ОЖИРІННЯ
Щепін, С., Артемьєв, М., & Антонець, О. (2022) · doi:10.32782/2522-1795.2022.12.13 · Cited by 4
Jacobs, A., Nawas, M. A., Deden, L. N., Dijksman, L. M., Boerma, E.-J. G., Demirkiran, A., Hazebroek, E. J., Wiezer, M. J., Derksen, W. J. M., & Monpellier, V. M. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06835-5 · Cited by 2
Rösch, S. A., Wünsche, L., Thiele, C., Reinstaller, T., Zaehle, T., Schag, K., Giel, K. E., Plewnia, C., Steiner, J., & Junne, F. (2024) · Journal of Eating Disorders · doi:10.1186/s40337-024-01160-3 · Cited by 3
Longitudinal dynamics of impulsivity in individuals undergoing obesity surgery – a systematic review
Giel, K. E., Camacho‐Barcia, L., Schultze-Rhonhof, L., Fernández‐Aranda, F., Zipfel, S., & Schag, K. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-10000-x · Cited by 2
Obesity Management: Implications for Contraceptive Counseling and Reproductive Health
Palmer, V., Grunvald, E. L., Sannidhi, D., & Mody, S. K. (2025) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-025-00445-x · Cited by 2
“It should be noted that the profound metabolic effects of these procedures are thought to be mediated through complex neuro-enteroendocrine mechanisms, with only a minor role from the gastrointestinal anatomic modifications [ 15].”
Masclee, G. M. C., & Masclee, A. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2593454 · Cited by 2
“The weight loss after bariatric surgery was initially attributed to anatomic restriction and/or reduced energy absorption, but nowadays it is understood that bariatric surgery has a variety of effects initiated by the remodeling of the gastrointestinal tract [87,88].”
Wang, W., Wang, Y., Guo, Z., Lu, Y., Xie, W., & Li, R. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07480-5 · Cited by 2
Jänis, M., Saarinen, T., Karppinen, J. E., Groop, P.-H., Neuvonen, M., Niemi, M., Juuti, A., Pietiläinen, K. H., & Heinonen, S. (2026) · International Journal of Obesity · doi:10.1038/s41366-025-01999-9 · Cited by 2
“Altered BA metabolism has been proposed to be one of the mechanisms behind the excellent and maintained results of bariatric surgery [6, 7].”
Experienced Weight Stigma Changes Following Bariatric Surgery: a Systematic Review and Meta‐Analysis
Farnsworth, H. R., Leget, D. L., LaCaille, L. J., LaCaille, R. A., Koball, A. M., Niemann, A., Backderf, C. Z., Mastrian, C. R., & Duyke, E. M. V. (2026) · Obesity Reviews · doi:10.1111/obr.70179 · Cited by 3
“First, it may be that physiological changes following MBS are stronger determinants in weight loss following MBS than psychosocial factors [83].”
The role of gut hormonal aspect in Iraqi patients subjected to sleeve Gastrectomy
Al-Amiri, R. M., Kadhum, H. S., & Ali, F. M. (2024) · Baghdad Science Journal · doi:10.21123/bsj.2024.8990 · Cited by 3
The Effect of Cholecystectomy on Weight Loss after Metabolic Bariatric Surgery
Cobar, J. P., Bond, D. S., Ebadinejad, A., Wu, Y., Santana, C., Steffen, K. J., Tishler, D. S., & Papasavas, P. K. (2025) · Obesity Surgery · doi:10.1007/s11695-025-07711-0 · Cited by 2
The Term Bariatric: Time for a Well-Deserved Retirement
Santoro, S., Shikora, S. A., & COHEN, R. V. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06624-0 · Cited by 2
“Today, there are several known neuroendocrine signals that the digestive tract generates to communicate to the rest of the body the precise amount of ingested nutrients which is critical information for the energy intake balance [8, 9].”
BackgroundCharacteristics of changes in plasma proteome profiling after sleeve gastrectomy
Zhang, Y., Shi, C., Wu, H., Yan, H., Xia, M., Jiao, H., Zhou, D., Wu, W., Zhong, M., Lou, W., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1330139 · Cited by 2
“Enhanced central appetite control, gut peptide release, alterations in microbiota, bile acids, insulin sensitivity, and insulin secretion have been recognized as contributors to improved metabolic health (9 – 12).”
BackgroundClinical efficacy and mechanism of action of medical devices for obesity and type 2 diabetes
Ansari, S., & Miras, A. D. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100324 · Cited by 1
Self-citationSalman, M. A., Conway, N., Bateman, L., Albon, L., Mabrook, M., Khalid, A., & Salman, A. (2024) · Bariatric Surgical Practice and Patient Care · doi:10.1089/bari.2023.0030 · Cited by 1
Seyedi, A., Rabizadeh, S., Abbaspour, F., Reyhan, S. K., Soran, N. A., Nabipoor, A., Yadegar, A., Mohammadi, F., Hashemi, R., Qahremani, R., et al. (2024) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2024.10.022 · Cited by 1
Gastric Remnant Perforation 10 Years After Roux-en-Y Gastric Bypass: A Report of a Rare Case
Pereira, H., Martins, D., Santos, M. A. D. S., Tavares, A. B., & de Oliveira, M. C. (2025) · Cureus · doi:10.7759/cureus.85077 · Cited by 2
A Strategy for Weight Loss and Weight Management - Review
Czyżnikiewicz, A., Rulewska, N. M., Siemko, J., Grabowski, F., Neska, D., Prystacka-Szar, D., Bujak, M., Waśniowska, M., Stołowski, W., & Stadler-Szajda, J. (2025) · Journal of Education Health and Sport · doi:10.12775/jehs.2025.82.60112 · Cited by 1
Kartnig, F., Prager, M., Herz, C. T., Kulterer, O. C., Khoshmehr, E. M., Horodecki-Tucheslau, R., Krebs, M., Prager, G., Kautzky‐Willer, A., & Kiefer, F. W. (2025) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2025.09.011 · Cited by 1
Fabrication and application of microneedle systems for adipose tissue reduction
Cai, T., Guo, M., Qin, S., Sun, D., Yu, X. J., Wang, C., & Yuan, Z. (2026) · Biomaterials Science · doi:10.1039/d5bm00716j · Cited by 1
Lin, Y., Yu, J., Duan, X., Liu, C., Gao, S., Zhang, X., Meng, H., & Liu, G. (2025) · BMC Psychology · doi:10.1186/s40359-025-03778-7 · Cited by 1
“However, substantial interindividual variability exists in postoperative outcomes and the degree of weight loss following metabolic bariatric surgery [4].”
Carprofen increases the risk of anastomotic leakage in a mouse model of Roux-en-Y gastric bypass
Claus, P., Springer, R., Otto, C., Seyfried, F., & Schlegel, N. (2025) · Laboratory Animals · doi:10.1177/00236772251391394 · Cited by 1
Mahmoud, A., Awad, K., Sheashaa, H., Mohammed, A., Farina, J., Pereyra, M., Scalia, I. G., Hafez, A. H., Senjab, A., Ibrahim, R., et al. (2026) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2026.100756 · Cited by 1
“Patients with refractory and resistant obesity are increasingly choosing to undergo bariatric surgery (BS) to mechanically reduce food intake and promote neurohormonal regulation which causes feelings of satiety [11].”
Xie, J., Yang, Y., Chen, W., (45927), L. W., Weng, S., Lyu, Q., & Cao, G. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00722-7 · Cited by 1
“Although the efficacy varies among individuals, this dual action of “appetite suppression and energy expenditure increase” may be the central mechanism by which bariatric surgery achieves substantial weight loss [7, 8].”
Metadata
- Authors
- Akalestou, E., Miras, A. D., Rutter, G. A., & le Roux, C. W.
- Affiliations
- Imperial College London (GB)
- Nanyang Technological University (SG)
- Diabetes Complications Research Centre, University College Dublin, Ireland
- Corresponding author
- Miras, Alexander D
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2021-08-07
- Volume
- 43
- Issue
- 1
- Pages
- 19-34
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC8755990
- OpenAlex
- W3192951577
- Cited by
- 136
- References
- 155
- Citations by year
- 2026: 25 · 2025: 37 · 2024: 31 · 2023: 18 · 2022: 21 · 2021: 2
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ulster University Research Portal (Ulster University) (publishedVersion, cc-by)
- DR-NTU (Nanyang Technological University) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Rosetrees Trust (M825)
- JP Moulton Charitable Foundation
- National Institute for Health Research
- Imperial College Healthcare Charity
- Novo Nordisk
- Wellcome Trust (212625/Z/18/Z)
- Medical Research Council (MR/R022259/1, MR/J0003042/1, MR/L020149/1)
- Irish Research Council (IRCLA/2017/234)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- bariatric surgery, weight loss mechanisms, obesity, energy expenditure, appetite regulation, gut peptides, gut microbiota, bile acids
- MeSH terms
- Energy Metabolism, Humans, Obesity, Weight Loss, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.